FEATUREDPHARMACEUTICALSJ&J Q3 Earnings: The US$100bn Revenue Goal Remains in ReachCollen GezaOctober 14, 2026October 14, 2026 by Collen GezaOctober 14, 2026October 14, 2026
FEATUREDPHARMACEUTICALSCSIR Takes Lead in South Africa’s Active Pharmaceutical Ingredient Innovation ClusterCollen GezaAugust 17, 2026August 17, 2026 by Collen GezaAugust 17, 2026August 17, 2026
